Contemporary clinical trialsLee JD, Nunes EV, Novo P, et al. NIDA Clinical Trials Network CTN-0051, extended release naltrexone vs buprenorphine for opioid treatment (X:BOT): study rationale and design. Contemp Clin Trials. 2016;50:253-264....
Addiction Science & Clinical Practice is pleased to announce an upcoming special series on the opioid use disorder (OUD) care continuum, specifically articles describing broad research and data supported by the National Drug Abuse Treatment Clinical Trials Network (CTN): its past effort in developing...
CTN BulletinClinical Trials April 9, 2008Network Volume 08 – 07CTN 0030 POATS Next Steering Committee MeetingThe Prescription Opiate Addiction Treatment The NIDA CTN Steering Committee Meeting will beStudy (POATS) sites continue to work hard held June 4-5, 2008 at the Hyatt Regency,recruiting pa...
The aim of the present study is to evaluate the efficacy and tolerability of risperidone in controlling aggressive behaviour in adults with mental retardation. Eighteen patients have been assessed for aggressivity through the Handicap Behaviour and Skill schedule (HBSs), for psychopathological aspects th...
The National Drug Abuse Treatment Clinical Trials Network (CTN) has faced many challenges over its first eleven years. This review explores some of these challenges and the paths the CTN took to meet these challenges, including: designing clinical trials that reflect the CTN's mission and changing...
The National Institute on Drug Abuse's Clinical Trials Network (CTN) is a practice-based research network that partners academic researchers with community based substance use disorder (SUD) treatment programs designed primarily to conduct effectiveness trials of promising interventions. A secondary goal ...
Underrepresentation in clinical trials limits the extent to which ethnic minorities benefit from advances in substance abuse treatment. The objective of this article is to share the knowledge gained within the Clinical Trials Network (CTN) of the National Institute on Drug Abuse and other research on...
This presentation, by Betty Tai, Director of the Center for the Clinical Trials Network at NIDA, begins with a brief description of the CTN history, its overall goals, and its rectified vision to bring drug abuse treatment into mainstream medical practice. It then describes the CTN research por...
The third annual Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling was held on November 29, 2018, at the American Society of Hematology (ASH) annual meeting. This workshop featured the latest research focused ...
The National Drug Abuse Treatment Clinical Trials Network (CTN) has faced many challenges over its first eleven years. This review explores some of these c... B Tai,Sparenborg,Liu,... - 《Substance Abuse & Rehabilitation》 被引量: 17发表: 2011年 substance abuse and rehabilitation dovepress ...